GlobeNewswire: Emerald Health Therapeutics Inc. Contains the last 10 of 220 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:57:47ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/07/01/2056123/0/en/Emerald-Health-Therapeutics-Announces-Completion-of-Accordion-Provision-of-Pure-Sunfarms-Credit-Facility.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms’ Credit Facility2020-07-01T11:00:00Z<![CDATA[Expanded facility provides additional financial resources and flexibility as Pure Sunfarms continues to build on its success to date as a leading Canadian cannabis producer and brand Expanded facility provides additional financial resources and flexibility as Pure Sunfarms continues to build on its success to date as a leading Canadian cannabis producer and brand]]>https://www.globenewswire.com/news-release/2020/06/24/2052612/0/en/Emerald-Health-Therapeutics-Joint-Venture-Pure-Sunfarms-Branded-Products-Ship-to-Saskatchewan-and-are-Approved-in-Manitoba.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics’ Joint Venture Pure Sunfarms’ Branded Products Ship to Saskatchewan and are Approved in Manitoba2020-06-24T11:00:00Z<![CDATA[Pure Sunfarms continues to launch new products, including pre-rolls, in Ontario and prepare launch of first Cannabis 2.0 products this summer Pure Sunfarms continues to launch new products, including pre-rolls, in Ontario and prepare launch of first Cannabis 2.0 products this summer]]>https://www.globenewswire.com/news-release/2020/06/23/2051825/0/en/Emerald-Health-Therapeutics-Verd%C3%A9lite-Launches-Souvenir-Cannabis-Brand-in-Qu%C3%A9bec.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics’ Verdélite Launches Souvenir™ Cannabis Brand in Québec2020-06-23T10:02:00Z<![CDATA[Verdélite offers craft cannabis products in its home province for Québec consumers Verdélite offers craft cannabis products in its home province for Québec consumers]]>Made in Québec.Souvenir LogoMade in QuébecChemdog - Souvenirhttps://www.globenewswire.com/news-release/2020/06/19/2050629/0/en/Emerald-Health-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update2020-06-19T11:00:00Z<![CDATA[VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com.]]>https://www.globenewswire.com/news-release/2020/06/11/2046770/0/en/Emerald-Health-Therapeutics-to-Host-2020-First-Quarter-Financial-Results-Conference-Call-on-Friday-June-19-2020-at-10-30-AM-ET.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET2020-06-11T11:00:00Z<![CDATA[VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will report its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, June 18, 2020. The company will host a conference call on Friday, June 19, 2020, at 10:30 a.m. ET.]]>https://www.globenewswire.com/news-release/2020/06/02/2042569/0/en/Emerald-Health-Therapeutics-Closes-2-1-Million-Prospectus-Sale.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale2020-06-02T20:05:00Z<![CDATA[NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES]]>https://www.globenewswire.com/news-release/2020/05/27/2039843/0/en/Emerald-Health-Therapeutics-Terminates-Land-Sub-lease-and-Outdoor-Cultivation-Agreements.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics Terminates Land Sub-lease and Outdoor Cultivation Agreements2020-05-27T23:54:46Z<![CDATA[VANCOUVER, British Columbia, May 27, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that it has terminated certain related party agreements pertaining to its cannabis cultivation operation in Metro Vancouver. Previously existing rights and continuing usage of the land and its cultivation operation in Metro Vancouver are unaffected by these terminations.]]>https://www.globenewswire.com/news-release/2020/05/25/2038056/0/en/Emerald-Health-Therapeutics-Announces-Pure-Sunfarms-Initial-Cultivation-and-Sales-License-for-Second-Greenhouse.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics Announces Pure Sunfarms’ Initial Cultivation and Sales License for Second Greenhouse2020-05-25T11:00:00Z<![CDATA[Pure Sunfarms intends to launch vape products this summer Pure Sunfarms intends to launch vape products this summer]]>https://www.globenewswire.com/news-release/2020/05/21/2036922/0/en/Emerald-Announces-2-1-Million-Prospectus-Sale.html?f=22&fvtc=4&fvtv=38532Emerald Announces $2.1 Million Prospectus Sale2020-05-21T11:00:00Z<![CDATA[NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES]]>https://www.globenewswire.com/news-release/2020/05/15/2034135/0/en/Emerald-Health-Therapeutics-Reports-Pure-Sunfarms-First-Quarter-2020-Financial-Results.html?f=22&fvtc=4&fvtv=38532Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results2020-05-15T11:00:00Z<![CDATA[Pure Sunfarms achieves fifth consecutive profitable quarter and 179% quarter-to-quarter growth in retail branded product sales volume; builds on retail success in Ontario with 20% market share in April; continues leadership in low-cost cultivation]]>